pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 2
hydroxyprogesterone caproate
Hydroxyprogesterone Caproate (hydroxyprogesterone caproate [INN])
Premature Labor (Tocolysis)
$LPCN
Lipocine Inc.
Marketed
hydroxyurea
Xromi (hydroxyurea)
Sickle Cell Disease With Vaso-Occlusive Crisis
Nova Laboratories Ltd
Phase 3
hypericin sodium
hypericin sodium
Cutaneous T-Cell Lymphoma
$SNGX
SOLIGENIX, INC.
← prev
page 48 of 62
next →
Pain
89
Neurology
1
Phase 2
iadademstat
iadademstat [INN]
Small-Cell Lung Cancer
Oryzon Genomics SA
Phase 2
ibcasertib
ibcasertib [INN]
Breast Cancer
Shenzhen Chipscreen Biosciences Co Ltd
Phase 3
ibrilatazar
ibrilatazar [INN]
Metastatic Pancreatic Cancer
Ability Pharmaceuticals SL
Marketed
ibritumomab tiuxetan
Zevalin (ibritumomab tiuxetan)
B-Cell Non-Hodgkin Lymphoma
Acrotech Biopharma Inc
Marketed
ibrutinib
Imbruvica (ibrutinib)
Follicular Lymphoma
$ABBV
AbbVie Inc.
Phase 3
ibudilast
ibudilast [INN]
Amyotrophic Lateral Sclerosis
$MNOV
MEDICINOVA INC
Marketed
idecabtagene vicleucel
Abecma (idecabtagene vicleucel)
Refractory Multiple Myeloma
Celgene Corp
Phase 2
idroxioleic acid
idroxioleic acid
Malignant Glioma
Laminar Pharmaceuticals SA
pre_registration
ifinatamab deruxtecan
ifinatamab deruxtecan
Small-Cell Lung Cancer
Daiichi Sankyo Co Ltd
Phase 2
imifoplatin
imifoplatin
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Promontory Therapeutics Inc
Phase 2
imneskibart
imneskibart
Colorectal Cancer
Aulos Bioscience Inc
Phase 2
imzokitug
imzokitug
Colorectal Cancer
Bristol-Myers Squibb Co
Phase 2
inlexisertib
inlexisertib
Gastrointestinal Stromal Tumor (GIST)
Deciphera Pharmaceuticals Inc
Phase 2
inobrodib
inobrodib
Refractory Multiple Myeloma
CellCentric Ltd
Marketed
inotuzumab ozogamicin
Besponsa (inotuzumab ozogamicin)
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…
$PFE
PFIZER INC
Marketed
interferon alfa-2b
Intron A (interferon alfa-2b)
Genital Warts (Condylomata Acuminata)
Schering-Plough Corp (Inactive)
Phase 2
intismeran autogene
intismeran autogene
Metastatic Melanoma
$MRNA
Moderna, Inc.
Phase 2
invikafusp alfa
invikafusp alfa [INN]
Triple-Negative Breast Cancer (TNBC)
Marengo Therapeutics Inc
Phase 2
iobenguane I 131
iobenguane I 131
Neuroblastoma
Jubilant DraxImage Inc
Phase 3
iodine i 131 apamistamab
Iomab-B (iodine i 131 apamistamab)
Refractory Acute Myeloid Leukemia
$ATNM
Actinium Pharmaceuticals, Inc.
Phase 2
iodofalan I 131
iodofalan I 131
Recurrent Glioblastoma Multiforme (GBM)
$TLX
Telix Pharmaceuticals Ltd
Phase 2
iopofosine i-131
iopofosine i-131
Multiple Myeloma (Kahler Disease)
$CLRB
Cellectar Biosciences, Inc.
Phase 3
ipilimumab + nivolumab
Opdivo + Yervoy (ipilimumab + nivolumab)
Gastric Cancer
Bristol-Myers Squibb Co
Phase 2
irinotecan
irinotecan [INN]
Gastric Cancer
Ascelia Pharma AB
pre_registration
isatuximab
Sarclisa (isatuximab-irfc)
Refractory Multiple Myeloma
$SNY
Sanofi
Marketed
istradefylline
Nourianz (istradefylline)
Parkinson's Disease
Kyowa Hakko USA Inc
Marketed
itraconazole
Tolsura (itraconazole)
Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal…
$INTI
Inhibitor Therapeutics, Inc.
